generalised convulsive status epilepticus
Neurology · 2022–2023
3decisions
2medicines
2carried consumer input
18individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| midazolam Generalised convulsive status epilepticus (GCSE) in patients aged over 6 months for initial and continuing treatment. | Nov 2023 | Recommended with restriction | 18 individuals |
| midazolam maleate Treatment of generalised convulsive status epilepticus (GCSE) in patients with epilepsy aged over 6 months and at high risk of status epilepticus. | Jul 2022 | Recommended with restriction | input received Epilepsy Australia · Epilepsy Action Australia |
| midazolam Treatment of generalised convulsive status epilepticus (GCSE) in patients with epilepsy aged over 6 months and a high risk of status epilepticus. | Nov 2022 | Recommended | unclear |
Who spoke
Epilepsy Australia · Epilepsy Action Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.